Growth Metrics

Ardelyx (ARDX) Operating Income (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Ardelyx 1.48 Bn 1.25 Bn 89.66 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -743.13%
Dec 31, 2025 9.23%
Sep 30, 2025 132.43%
Jun 30, 2025 60.40%
Mar 31, 2025 -547.37%
Dec 31, 2024 263.86%
Sep 30, 2024 116.38%
Jun 30, 2024 44.77%
Mar 31, 2024 11.82%
Dec 31, 2023 -478.29%
Sep 30, 2023 144.50%
Jun 30, 2023 36.22%
Mar 31, 2023 -314.64%
Dec 31, 2022 155.50%
Sep 30, 2022 16.54%
Jun 30, 2022 5.73%
Mar 31, 2022 21.17%
Dec 31, 2021 16.49%
Sep 30, 2021 5.79%
Jun 30, 2021 -40.08%
Mar 31, 2021 -15.78%
Dec 31, 2020 -61.08%
Sep 30, 2020 29.11%
Jun 30, 2020 -11.20%
Mar 31, 2020 -15.50%
Dec 31, 2019 14.67%
Sep 30, 2019 11.03%
Jun 30, 2019 2.63%
Mar 31, 2019 6.86%
Dec 31, 2018 -15.35%
Sep 30, 2018 -7.12%
Jun 30, 2018 -25.27%
Mar 31, 2018 -261.33%
Dec 31, 2017 151.65%
Sep 30, 2017 19.66%
Jun 30, 2017 7.09%
Mar 31, 2017 9.66%
Dec 31, 2016 -7.79%
Sep 30, 2016 -1.78%
Jun 30, 2016 -21.93%
Mar 31, 2016 -39.42%
Dec 31, 2015 6.65%
Sep 30, 2015 -299.64%
Jun 30, 2015 359.48%
Mar 31, 2015 11.26%
Dec 31, 2014 -4,955.56%
Sep 30, 2014 -97.06%
Jun 30, 2014 692.89%
Mar 31, 2014 35.38%
Dec 31, 2013 18.96%
Sep 30, 2013 -4.11%